What Do the Newer Trials Tell Us About the Management of Heart Failure? A Discussion of Three Thought-Provoking Papers

Moderator:

Discussants:

  • Summary:

    Dr. Douglas Schocken from the Duke Heart Center moderated the topic "What Do the Newer Trials Tell Us About the Management of Heart Failure? A Discussion of Three Thought-Provoking Papers" with Drs. Stephen S. Gottlieb from the University of Maryland School of Medicine, Lynne Warner Stevenson from the Brigham and Women's Hospital and James Young from the Cleveland Clinic participating.

    The discussion focused primarily on:
    Management of chronic heart failure by reviewing the findings of three papers published in 2009 on the use of intravenous iron, BNP biomarkers and ventricular assist devices:
    (1) Dr. Anker et al. addressed a novel medical approach to the problem by using intravenous ferric carboxymaltose,
    (2) Dr. Pfisterer et al. examined the way in which physicians assess medical management and thereby modify therapies , and
    (3) Dr. Slaughter et al. considered a fresh look at a newer type of mechanical ventricular assist device for failing hearts.
    (Med Roundtable Cardiovasc Ed. 2010;1(1):111-119) ©2010 FoxP2 Media, LLC
  • Compounds:
    Trials:

    ATLAS, BATTLESCARRED, FAIR-HF, HeartMate II, RABBITT, REMATCH, REVIVE IT, SENIORS, Time CHF

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.